Erratum: Notice of Retraction: Harada S, Yamazaki Y, and Tokuyama S (2013) Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor, J Pharmacol Exp Ther, 344: 276-285; DOI: https://doi.org/10.1124/jpet.112.199604);Orexin-A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain-derived neurotrophic factor

Journal of Pharmacology and Experimental Therapeutics

Volumn 344, Issue 1, 2013, Pages 276-285

  Harada, Shinichi ^a   Yamazaki, Yui ^a   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PROTEIN; GLUCOSE; INSULIN; INSULIN RECEPTOR; OREXIN A; SMALL INTERFERING RNA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG INHIBITION; ENZYME REPRESSION; GLUCOSE INTOLERANCE; HISTOLOGY; HYPOTHALAMUS; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TISSUE LEVEL; TREATMENT RESPONSE;

EID: 84871690112     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/JPET.112.199604RETRACTION     Document Type: Erratum

References (44)

1. Bellolio MF, Gilmore RM, and Stead LG (2011) Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev (9):CD005346.
2. Berglund ED, Vianna CR, Donato J, Jr, Kim MH, Chuang JC, Lee CE, Lauzon DA, Lin P, Brule LJ, and Scott MM, et al. (2012) Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest 122:1000-1009.
3. Blouet C and Schwartz GJ (2010) Hypothalamic nutrient sensing in the control of energy homeostasis. Behav Brain Res 209:1-12.
4. Brüning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Müller-Wieland D, and Kahn CR (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125.
5. Capes SE, Hunt D, Malmberg K, Pathak P, and Gerstein HC (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426-2432. (Pubitemid 32954818)
6. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, and Bartlett FS, et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95:322-327. (Pubitemid 28103952)
7. Dietrich WD, Alonso O, and Busto R (1993) Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 24:111-116. (Pubitemid 23014392)
8. Han BH and Holtzman DM (2000) BDNF protects the neonatal brain from hypoxicischemic injury in vivo via the ERK pathway. J Neurosci 20:5775-5781. (Pubitemid 30636906)
9. Harada S, Fujita WH, Shichi K, and Tokuyama S (2009a) The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res 1279:174-181.
10. Harada S, Fujita-Hamabe W, and Tokuyama S (2011) Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage. J Pharmacol Sci 115:155-163.
11. Harada S, Fujita-Hamabe W, and Tokuyama S (2012a) Ameliorating effect of hypothalamic brain-derived neurotrophic factor against impaired glucose metabolism after cerebral ischemic stress in mice. J Pharmacol Sci 118:109-116.
12. Harada S, Fujita-Hamabe W, and Tokuyama S (2012b) Ischemic stroke and glucose intolerance: a review of the evidence and exploration of novel therapeutic targets. J Pharmacol Sci 118:1-13.
13. Harada S, Hamabe W, Kamiya K, Satake T, Yamamoto J, and Tokuyama S (2009b) Preventive effect of Morinda citrifolia fruit juice on neuronal damage induced by focal ischemia. Biol Pharm Bull 32:405-409.
14. Harrison TA, Chen CT, Dun NJ, and Chang JK (1999) Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla. Neurosci Lett 273:17-20. (Pubitemid 29415692)
15. Hwang LL, Chen CT, and Dun NJ (2001) Mechanisms of orexin-induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro. J Physiol 537:511-520.
16. Imai J, Katagiri H, Yamada T, Ishigaki Y, Suzuki T, Kudo H, Uno K, Hasegawa Y, Gao J, and Kaneko K, et al. (2008) Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science 322:1250-1254.
17. Irving EA, Harrison DC, Babbs AJ, Mayes AC, Campbell CA, Hunter AJ, Upton N, and Parsons AA (2002) Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neurosci Lett 324:53-56. (Pubitemid 34442676)
18. Karnani M and Burdakov D (2011) Multiple hypothalamic circuits sense and regulate glucose levels. Am J Physiol Regul Integr Comp Physiol 300:R47-R55.
19. Liao GY, An JJ, Gharami K, Waterhouse EG, Vanevski F, Jones KR, and Xu B (2012) Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin. Nat Med 18:564-571.
20. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, and Elmquist JK (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435:6-25. (Pubitemid 32448719)
21. Marino JS, Xu Y, and Hill JW (2011) Central insulin and leptin-mediated autonomic control of glucose homeostasis. Trends Endocrinol Metab 22:275-285.
22. Matz K, Keresztes K, Tatschl C, Nowotny M, Dachenhausen A, Brainin M, and Tuomilehto J (2006) Disorders of glucose metabolism in acute stroke patients: an underrecognized problem [erratum in Diabetes Care. 2006;29:1723]. Diabetes Care 29:792-797. (Pubitemid 44115296)
23. Nakagawa T, Tsuchida A, Itakura Y, Nonomura T, Ono M, Hirota F, Inoue T, Nakayama C, Taiji M, and Noguchi H (2000) Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 49:436-444. (Pubitemid 30131790)
24. Nonomura T, Tsuchida A, Ono-Kishino M, Nakagawa T, Taiji M, and Noguchi H (2001) Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice. Int J Exp Diabetes Res 2:201-209.
25. Ohtsubo K, Chen MZ, Olefsky JM, and Marth JD (2011) Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med 17:1067-1075.
26. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, and Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015. (Pubitemid 28543775)
27. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, and Rossetti L (2005) Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434:1026-1031. (Pubitemid 40586051)
28. Prodi E and Obici S (2006) Minireview: the brain as a molecular target for diabetic therapy. Endocrinology 147:2664-2669. (Pubitemid 43764601)
29. Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, Yesavage J, Di Monte D, Dohi K, Melberg A, and Lammers GJ, et al. (2001) CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57:2253-2258. (Pubitemid 34016460)
30. Sakurai T (2007) The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8:171-181.
31. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, and Wilson S, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585. (Pubitemid 28101119)
32. Shichi K, Fujita-Hamabe W, Harada S, Mizoguchi H, Yamada K, Nabeshima T, and Tokuyama S (2011) Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage. J Pharmacol Exp Ther 338:701-710.
33. Shimazu T and Ogasawara S (1975) Effects of hypothalamic stimulation on gluconeogenesis and glycolysis in rat liver. Am J Physiol 228:1787-1793.
34. Shiuchi T, Haque MS, Okamoto S, Inoue T, Kageyama H, Lee S, Toda C, Suzuki A, Bachman ES, and Kim YB, et al. (2009) Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system. Cell Metab 10:466-480.
35. Silva JP, von Meyenn F, Howell J, Thorens B, Wolfrum C, and Stoffel M (2009) Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 462:646-650.
36. Toriya M, Maekawa F, Maejima Y, Onaka T, Fujiwara K, Nakagawa T, Nakata M, and Yada T (2010) Long-term infusion of brain-derived neurotrophic factor reduces food intake and body weight via a corticotrophin-releasing hormone pathway in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 22:987-995.
37. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, and Guan XM (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438:71-75. (Pubitemid 28517837)
38. Tsao D, Thomsen HK, Chou J, Stratton J, Hagen M, Loo C, Garcia C, Sloane DL, Rosenthal A, and Lin JC (2008) TrkB agonists ameliorate obesity and associated metabolic conditions in mice. Endocrinology 149:1038-1048. (Pubitemid 351397944)
39. Tsuchida A, Nakagawa T, Itakura Y, Ichihara J, Ogawa W, Kasuga M, Taiji M, and Noguchi H (2001) The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Diabetologia 44:555-566. (Pubitemid 32411271)
40. Tsuneki H, Sugihara Y, Honda R, Wada T, Sasaoka T, and Kimura I (2002) Reduction of blood glucose level by orexins in fasting normal and streptozotocin-diabetic mice. Eur J Pharmacol 448:245-252. (Pubitemid 34874594)
41. Widmer H, Abiko H, Faden AI, James TL, and Weinstein PR (1992) Effects of hyperglycemia on the time course of changes in energy metabolism and pH during global cerebral ischemia and reperfusion in rats: correlation of 1H and 31P NMR spectroscopy with fatty acid and excitatory amino acid levels. J Cereb Blood Flow Metab 12:456-468.
42. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, and Reichardt LF (2003) Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6:736-742. (Pubitemid 36792889)
43. Yamada T and Katagiri H (2007) Avenues of communication between the brain and tissues/organs involved in energy homeostasis. Endocr J 54:497-505. (Pubitemid 47414595)
44. Yuan LB, Dong HL, Zhang HP, Zhao RN, Gong G, Chen XM, Zhang LN, and Xiong L (2011) Neuroprotective effect of orexin-A is mediated by an increase of hypoxia-inducible factor-1 activity in rat. Anesthesiology 114:340-354.